Aberdeen Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430M | Buy |
|
|||||
|
2025
Q1 | $466M | Buy |
|
|||||
|
2024
Q4 | $311M | Sell |
|
|||||
|
2024
Q3 | $389M | Sell |
|
|||||
|
2024
Q2 | $352M | Sell |
|
|||||
|
2024
Q1 | $411M | Sell |
|
|||||
|
2023
Q4 | $352M | Buy |
|
|||||
|
2023
Q3 | $215M | Sell |
|
|||||
|
2023
Q2 | $213M | Sell |
|
|||||
|
2023
Q1 | $436M | Sell |
|
|||||
|
2022
Q4 | $459M | Sell |
|
|||||
|
2022
Q3 | $385M | Sell |
|
|||||
|
2022
Q2 | $463M | Sell |
|
|||||
|
2022
Q1 | $594M | Sell |
|
|||||
|
2021
Q4 | $657M | Buy |
|
|||||
|
2021
Q3 | $512M | Sell |
|
|||||
|
2021
Q2 | $531M | Buy |
|
|||||
|
2021
Q1 | $494M | Buy |
|
|||||
|
2020
Q4 | $462M | Buy |
|
|||||
|
2020
Q3 | $361M | Sell |
|
|||||
|
2020
Q2 | $421M | Buy |
|
|||||
|
2020
Q1 | $300M | Buy |
|
|||||
|
2019
Q4 | $198M | Buy |
|
|||||
|
2019
Q3 | $166M | Buy |
|
|||||
|
2019
Q2 | $69.9M | Buy |
|
|||||
|
2019
Q1 | $72M | Buy |
|
|||||
|
2018
Q4 | $69.5M | Sell |
|
|||||
|
2018
Q3 | $77.9M | Sell |
|
|||||
|
2018
Q2 | $96.9M | Sell |
|
|||||
|
2018
Q1 | $263M | Buy |
|
|||||
|
2017
Q4 | $261M | Buy |
|
|||||
|
2017
Q3 | $177M | Buy |
|